Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Stanford University
Summary
The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer. Depending on the location and size of the tumor.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Histologically or cytologically documented malignancy of the lung including non-small cell lung cancer or small cell lung cancer planned for definitive therapy with fractionated radiation (60-66 Gy) and concurrent systemic therapy * ECOG performance status of 0-2 * Age ≥ 18 years old * Ability to understand and the willingness to personally sign the written IRB approved informed consent document * Estimated life expectancy of 12 weeks or longer Exclusion Criteria: * Contraindication to receiving radiotherapy or systemic therapy as determined by treating radiation and m…
Interventions
- RadiationHypofractionated accelerated radiation therapy
Hypofractionated accelerated radiation therapy
Locations (2)
- Stanford UniversityPalo Alto, California
- Stanford Cancer Center South BaySan Jose, California